FI108228B - Menetelmä terapeuttisesti käyttökelpoisten atsabisyklokinolonikarboksyylihappojen valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten atsabisyklokinolonikarboksyylihappojen valmistamiseksi

Info

Publication number
FI108228B
FI108228B FI920632A FI920632A FI108228B FI 108228 B FI108228 B FI 108228B FI 920632 A FI920632 A FI 920632A FI 920632 A FI920632 A FI 920632A FI 108228 B FI108228 B FI 108228B
Authority
FI
Finland
Prior art keywords
carboxylic acids
azabicycloquinolone
preparation
therapeutically useful
alkyl
Prior art date
Application number
FI920632A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI920632A0 (fi
Inventor
Katherine Elizabeth Brighty
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI920632A0 publication Critical patent/FI920632A0/fi
Priority to FI964520A priority Critical patent/FI103879B/fi
Application granted granted Critical
Publication of FI108228B publication Critical patent/FI108228B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI920632A 1989-08-16 1992-02-14 Menetelmä terapeuttisesti käyttökelpoisten atsabisyklokinolonikarboksyylihappojen valmistamiseksi FI108228B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI964520A FI103879B (fi) 1989-08-16 1996-11-11 Atsabisykloyhdisteet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/003489 WO1991002526A1 (en) 1989-08-16 1989-08-16 Azabicyclo quinolone carboxylic acids

Publications (2)

Publication Number Publication Date
FI920632A0 FI920632A0 (fi) 1992-02-14
FI108228B true FI108228B (fi) 2001-12-14

Family

ID=22215165

Family Applications (2)

Application Number Title Priority Date Filing Date
FI920632A FI108228B (fi) 1989-08-16 1992-02-14 Menetelmä terapeuttisesti käyttökelpoisten atsabisyklokinolonikarboksyylihappojen valmistamiseksi
FI964520A FI103879B (fi) 1989-08-16 1996-11-11 Atsabisykloyhdisteet

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI964520A FI103879B (fi) 1989-08-16 1996-11-11 Atsabisykloyhdisteet

Country Status (30)

Country Link
EP (1) EP0413455B1 (es)
JP (2) JPH072734B2 (es)
KR (1) KR930004844B1 (es)
CN (1) CN1025192C (es)
AT (1) ATE124040T1 (es)
AU (1) AU623801B2 (es)
BA (1) BA98299A (es)
CA (2) CA2127561C (es)
CY (1) CY1969A (es)
CZ (1) CZ281127B6 (es)
DD (1) DD298399A5 (es)
DE (3) DE19875052I2 (es)
DK (1) DK0413455T3 (es)
EG (1) EG19251A (es)
ES (1) ES2074131T4 (es)
FI (2) FI108228B (es)
GR (1) GR3017072T3 (es)
HK (1) HK1000207A1 (es)
HU (2) HU219403B (es)
IE (1) IE66202B1 (es)
IL (1) IL95331A (es)
LU (2) LU90311I2 (es)
NL (2) NL980032I2 (es)
NO (1) NO300214B1 (es)
NZ (1) NZ234920A (es)
PL (1) PL166381B1 (es)
PT (1) PT94998B (es)
RU (1) RU2049777C1 (es)
WO (1) WO1991002526A1 (es)
ZA (1) ZA906450B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
FR2675144B1 (fr) * 1991-04-10 1995-06-16 Bouchara Sa Nouvelles quinolones difluorees - leur procede de preparation et les compositions pharmaceutiques en renfermant.
CA2111463C (en) * 1991-06-19 1997-08-26 Bingwei V. Yang Azaspiro quinolone antibacterial agents
US5256791A (en) * 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
US5527910A (en) * 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
US5591766A (en) * 1993-12-03 1997-01-07 Cheil Foods & Chemicals, Inc. Solid oral formulations of pyridone carboxylic acids
JP2848538B2 (ja) * 1994-02-04 1999-01-20 大日本製薬株式会社 ２環性アミノ基で置換されたピリドンカルボン酸誘導体、そのエステルおよびその塩ならびにこれらの中間体たる２環性アミン
ES2315432T3 (es) * 1995-02-02 2009-04-01 Daiichi Sankyo Company, Limited Derivados de acido piridonacarboxilico y su uso como agentes antibacterianos.
JPH08213881A (ja) * 1995-02-02 1996-08-20 Fujitsu Ltd 周波数制御回路
DK0816355T3 (da) * 1995-02-07 2003-08-18 Daiichi Seiyaku Co Heterocykliske spiroderivater
ES2117426T3 (es) * 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
DK0833837T3 (da) * 1995-06-15 2002-09-02 Pfizer Fremgangsmåde til fremstilling af derivater af azabicyclonaphthydridincarboxylsyre omfattende et dipeptid
HU228567B1 (en) * 1996-02-09 2013-04-29 Toyama Chemical Co Ltd Quinolonecarboxylic acid derivatives or salts thereof
AP788A (en) * 1996-08-26 1999-12-03 Pfizer Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt.
TW519542B (en) * 1996-09-27 2003-02-01 Daiichi Seiyaku Co Bicyclic amine derivative
CN1103769C (zh) 1996-10-25 2003-03-26 第一制药株式会社 三环胺衍生物
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
DE19733439A1 (de) * 1997-08-02 1999-02-04 Bayer Ag Neue 6-endo-Amino-3-azabicyclo(3.1.0)hexande, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Chinolon- und Naphthyridincarbonsäure-Derviaten mit verbesserten Eigenschaften
MY138335A (en) 1997-09-15 2009-05-29 Procter & Gamble Antimicrobial quinolones, their compositions and uses
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
CA2367373C (en) 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
ES2249489T3 (es) 2000-12-14 2006-04-01 THE PROCTER & GAMBLE COMPANY Quinolonas antimicrobianas.
NZ525570A (en) 2000-12-14 2005-04-29 Procter & Gamble Antimicrobial 2-pyridones, their compositions and uses
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
BR0215801A (pt) 2002-07-08 2005-05-10 Ranbaxy Lab Ltd Derivados de 3,6-dissubstituìdos azabiciclo [3.1.0] hexano úteis como antagonistas de receptores muscarìnicos
CN1688544A (zh) 2002-08-23 2005-10-26 兰贝克赛实验室有限公司 作为蕈毒碱受体拮抗剂的含氟代和磺酰氨基的3,6－二取代的氮杂双环(3.1.0)己烷衍生物
WO2004089898A1 (en) 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
DE60313898T2 (de) 2003-04-10 2008-01-17 Ranbaxy Laboratories, Ltd. Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten
CN100436414C (zh) 2003-04-11 2008-11-26 兰贝克赛实验室有限公司 作为毒蕈碱受体拮抗剂的氮杂双环衍生物
EP1670759A1 (en) * 2003-09-18 2006-06-21 Ranbaxy Laboratories Limited PROCESS FOR THE PREPARATION OF (1a, 5a, 6a)-6-AMINOME THYL-3-BENZYL-3-AZABICYCLO 3.1.0 HEXANE
MX2008012328A (es) 2006-03-28 2008-10-09 Procter & Gamble Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil- piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinc arboxilico.
JP2009531418A (ja) 2006-03-28 2009-09-03 ザ プロクター アンド ギャンブル カンパニー キノロン中間体調製のためのカップリング方法
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
JP2013542929A (ja) 2010-09-28 2013-11-28 パナセア バイオテック リミテッド 新規ビシクロ環化合物
WO2020073031A1 (en) * 2018-10-05 2020-04-09 New York University Fused bicyclic heterocycles as thereapeutic agents
CN112442084B (zh) * 2020-12-03 2022-09-09 国药集团致君（深圳）制药有限公司 一种抗菌药中间体的制备方法
CN113307768B (zh) * 2021-04-29 2023-12-12 中国农业科学院兰州畜牧与兽药研究所 喹诺酮类衍生物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676400B2 (ja) * 1987-08-25 1994-09-28 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
US4973091A (en) * 1989-09-20 1990-11-27 Truth Incorporated Sliding patio door dual point latch and lock

Also Published As

Publication number Publication date
JPH0819099B2 (ja) 1996-02-28
KR930004844B1 (ko) 1993-06-09
PL286484A1 (en) 1991-05-20
BA98299A (bs) 2001-09-14
PL166381B1 (pl) 1995-05-31
AU623801B2 (en) 1992-05-21
ATE124040T1 (de) 1995-07-15
CZ281127B6 (cs) 1996-06-12
NL980032I1 (nl) 1999-02-01
IL95331A0 (en) 1991-06-30
CA2127561A1 (en) 1991-02-17
NZ234920A (en) 1992-06-25
NL980032I2 (nl) 1999-05-03
DE19875052I2 (de) 2009-05-28
EG19251A (en) 1994-09-29
WO1991002526A1 (en) 1991-03-07
CY1969A (en) 1997-09-05
DE69020262D1 (de) 1995-07-27
CN1025192C (zh) 1994-06-29
DD298399A5 (de) 1992-02-20
NL980033I1 (nl) 1999-02-01
NO920599D0 (no) 1992-02-14
LU90311I2 (fr) 1999-01-25
HU211681A9 (en) 1995-12-28
DE69020262T2 (de) 1995-10-26
NO300214B1 (no) 1997-04-28
HU219403B (hu) 2001-04-28
NL980033I2 (nl) 1999-05-03
PT94998A (pt) 1991-04-18
CN1049501A (zh) 1991-02-27
GR3017072T3 (en) 1995-11-30
LU90310I2 (fr) 1999-01-25
JPH0386875A (ja) 1991-04-11
RU2049777C1 (ru) 1995-12-10
EP0413455A2 (en) 1991-02-20
JPH072734B2 (ja) 1995-01-18
IL95331A (en) 1995-07-31
IE66202B1 (en) 1995-12-13
CA2023217C (en) 1996-12-10
CA2023217A1 (en) 1991-02-17
FI964520A0 (fi) 1996-11-11
CA2127561C (en) 1998-07-28
FI920632A0 (fi) 1992-02-14
AU6104290A (en) 1991-02-21
FI103879B1 (fi) 1999-10-15
FI103879B (fi) 1999-10-15
NO920599L (no) 1992-04-14
EP0413455A3 (en) 1991-10-09
IE902950A1 (en) 1991-02-27
ZA906450B (en) 1992-03-25
PT94998B (pt) 1997-05-28
DE19875050I2 (de) 2009-05-28
HK1000207A1 (en) 1998-02-06
EP0413455B1 (en) 1995-06-21
ES2074131T3 (es) 1995-09-01
ES2074131T4 (es) 1996-05-01
JPH07149758A (ja) 1995-06-13
KR910004572A (ko) 1991-03-28
DK0413455T3 (da) 1995-08-14
FI964520A (fi) 1996-11-11
CZ402790A3 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
FI108228B (fi) Menetelmä terapeuttisesti käyttökelpoisten atsabisyklokinolonikarboksyylihappojen valmistamiseksi
EE02950B1 (et) Metüleenbisfosfoonhappe esteramiidderivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon
HUT59919A (en) Process for producing azabicyclo-quinolon and naphtiridone derivatives and pharmaceutical compositions containing them
ES8606326A1 (es) Acidos 1, 3-dioxan-4-ilalquenoicos
JPS5297934A (en) N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s
ATE205189T1 (de) Benzolsulfonylamin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
JPS5716856A (en) 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation
ES8604232A1 (es) Un procedimiento para la preparacion de derivados de penicilina
JPS5618948A (en) Peptide derivative
AR248025A1 (es) Procedimiento de obtencion de pirrolo/2, 3-b/indol-cetonas y compuestos analogos, utiles como medicamentos.
JPS5745190A (en) Novel 7alpha-methoxycephalosporin
HUT58098A (en) Process for producing quinolonecarboxylic acids substituted with bridged azabicyclic group substituted with amino group, as well as pharmaceutical compositions comprising same
JPS5315394A (en) Novel penicillins and cephalospolins and their preparation
JPS5573682A (en) 1-carba-1-penem-3-carboxylic acid derivative and its preparation
JPS57106690A (en) 2-aminoethylphosphonic acid derivative

Legal Events

Date Code Title Description
SPCF Supplementary protection certificate application filed

Spc suppl protection certif: L20020010

SPCG Supplementary protection certificate granted

Spc suppl protection certif: L198

Extension date: 20130326